Login to Your Account

NewCo News: Tarix Targeting the Other RAS Pathway via Angiotensin (1-7)

By Jennifer Boggs

Thursday, October 6, 2011
The renin angiotensin system (RAS) is hardly a new discovery in biotech – previous work led to widely used drugs such as ACE inhibitors for treating blood pressure and congestive heart failure – but only in recent years has the function of a second RAS pathway come to the attention of drug developers.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription